Alternative versus matched unrelated donor in adolescents and young adults transplanted for acute myeloid leukemia in first complete remission: A report from the SFGM-TC.
AuteursFourmont AM, Beauvais D, Balsat M, Maertens J, Forcade E, Huynh A, Poiré X, Devillier R, Castilla-Llorente C, Chevallier P, Pochon C, Daguindau E, Lewalle P, Bulabois CE, Brissot E, Raus N, Lambert J, Nguyen S, Dhédin N, Vasseur L
Transcriptomic insights into lobular breast cancer biology and patient outcomes: analysis of the MINDACT clinical trial.
AuteursDesmedt C, Nguyen HL, Richard F, Linn S, Metzger Fihlo O, Poncet C, Wesseling J, Aalders K, Delorenzi M, Delaloge S, Pierga JY, Brain E, Vrijaldenhoven S, Van Baelen K, Maetens M, Rutgers E, Piccart M, van 't Veer L, Viale G, Cardoso F
Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study.
AuteursBecherini C, Blondeaux E, Delucchi V, Visani L, Kim HJ, Coussy F, Bernstein-Molho R, Di Meglio A, Hilbers FS, Pogoda K, Kwong A, Agostinetto E, Baten A, Bajpai J, Balmana J, Moore HCF, Partridge AH, Rousset-Jablonski C, Phillips KA, Toss A, Renaud T, Ferrari A, Peccatori FA, Sanchez L, Paluch-Shimon S, Cui W, Wong SM, Ryu JM, Fruscio R, Lee MK, Vernieri C, Matikas A, Couch FJ, De Marchis L, Dieci MV, Aguilar-Y-Mendez D, Hwang SE, Rozenblit M, Can Güven D, Mrinakova B, Harbeck N, Sanchez-Bayona R, Boni L, Lambertini M, Meattini I
Reply regarding the European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer.
AuteursBrunelli A, Hardavella G, Huber RM, Berghmans T, Frille A, Rodriguez M, Tietzova I, Depypere L, Asteggiano R, Batchelor T, Costantini A, De Ruysscher D, Faivre-Finn C, Ferguson M, Langer D, Marczin N, Novoa N, Pompili C, Rawlinson J, Snoeckx A, van Geffen WH, Williams C, Blum TG
Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP).
AuteursAndreozzi F, Galimard JE, Maertens J, Aljurf M, Clesham K, Sanz J, Maury S, Loron S, Passweg J, Schroeder T, Salmenniemi U, van Gorkom G, Peffault de Latour R, von dem Borne PA, Locatelli F, Wynn RF, Dalle JH, Esteve J, Nagler A, Kleinschmidt K, Mohty M, Kalwak K, Ciceri F
Imlunestrant with or without abemaciclib in advanced breast cancer: safety analyses from the EMBER-3 trial.
AuteursO'Shaughnessy J, Bidard FC, Neven P, Casalnuovo ML, Aftimos P, Saura C, Harbeck N, Carey LA, Curigliano G, Garcia-Saenz JA, Abad MF, Paula L, Park YH, Ozyilkan O, Munoz M, Barrett E, Cao S, Chawla A, Jhaveri KL
